EE200300357A - 2-amino-1-(4-hüdroksü-3-metaansulfoonamidofenüül)-etanooli kasutamine uriinipidamatuse raviks - Google Patents

2-amino-1-(4-hüdroksü-3-metaansulfoonamidofenüül)-etanooli kasutamine uriinipidamatuse raviks

Info

Publication number
EE200300357A
EE200300357A EEP200300357A EEP200300357A EE200300357A EE 200300357 A EE200300357 A EE 200300357A EE P200300357 A EEP200300357 A EE P200300357A EE P200300357 A EEP200300357 A EE P200300357A EE 200300357 A EE200300357 A EE 200300357A
Authority
EE
Estonia
Prior art keywords
methanesulfonamidophenyl
hydroxy
ethanol
amino
treatment
Prior art date
Application number
EEP200300357A
Other languages
English (en)
Estonian (et)
Inventor
Pouzet Pascale
Esser Franz
Kitagawa Hisato
Ishiguro Naoki
Muramatsu Ikunobu
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300357A publication Critical patent/EE200300357A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/35Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200300357A 2001-02-01 2002-01-15 2-amino-1-(4-hüdroksü-3-metaansulfoonamidofenüül)-etanooli kasutamine uriinipidamatuse raviks EE200300357A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104369A DE10104369A1 (de) 2001-02-01 2001-02-01 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
PCT/EP2002/000311 WO2002060421A2 (en) 2001-02-01 2002-01-15 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence

Publications (1)

Publication Number Publication Date
EE200300357A true EE200300357A (et) 2003-10-15

Family

ID=7672382

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300357A EE200300357A (et) 2001-02-01 2002-01-15 2-amino-1-(4-hüdroksü-3-metaansulfoonamidofenüül)-etanooli kasutamine uriinipidamatuse raviks

Country Status (26)

Country Link
EP (1) EP1363614B1 (cs)
JP (1) JP2004517158A (cs)
KR (1) KR20030075173A (cs)
CN (1) CN1489459A (cs)
AR (1) AR035778A1 (cs)
AT (1) ATE293966T1 (cs)
BG (1) BG108033A (cs)
BR (1) BR0206854A (cs)
CA (1) CA2434565A1 (cs)
CZ (1) CZ20032097A3 (cs)
DE (2) DE10104369A1 (cs)
DK (1) DK1363614T3 (cs)
EA (1) EA200300789A1 (cs)
EC (1) ECSP034684A (cs)
EE (1) EE200300357A (cs)
ES (1) ES2240708T3 (cs)
HU (1) HUP0302752A2 (cs)
IL (1) IL156730A0 (cs)
MX (1) MXPA03006816A (cs)
NO (1) NO20033428L (cs)
PL (1) PL361731A1 (cs)
PT (1) PT1363614E (cs)
SK (1) SK9772003A3 (cs)
UY (1) UY27145A1 (cs)
WO (1) WO2002060421A2 (cs)
ZA (1) ZA200305201B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
CN113413393B (zh) * 2013-08-19 2025-03-04 塔里斯生物医药公司 多单元药物递送装置和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US341584A (en) * 1886-05-11 Device foe
GB993584A (cs) * 1962-01-24
KR0150649B1 (ko) * 1990-02-07 1998-10-15 아만 히데아키 술폰아닐리드 유도체 및 의약
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
WO1996038143A1 (en) * 1995-06-02 1996-12-05 Synaptic Pharmaceutical Corporation The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees

Also Published As

Publication number Publication date
BG108033A (bg) 2004-12-30
UY27145A1 (es) 2002-08-30
ECSP034684A (es) 2003-08-29
NO20033428D0 (no) 2003-07-31
DE60203882D1 (de) 2005-06-02
PT1363614E (pt) 2005-06-30
HUP0302752A2 (hu) 2003-11-28
CN1489459A (zh) 2004-04-14
MXPA03006816A (es) 2004-05-14
SK9772003A3 (sk) 2005-03-04
PL361731A1 (en) 2004-10-04
DE10104369A1 (de) 2002-08-08
NO20033428L (no) 2003-09-30
JP2004517158A (ja) 2004-06-10
EP1363614B1 (en) 2005-04-27
EP1363614A2 (en) 2003-11-26
IL156730A0 (en) 2004-02-08
KR20030075173A (ko) 2003-09-22
BR0206854A (pt) 2004-01-13
EA200300789A1 (ru) 2004-02-26
WO2002060421A2 (en) 2002-08-08
ES2240708T3 (es) 2005-10-16
CZ20032097A3 (cs) 2003-12-17
WO2002060421A3 (en) 2002-12-19
CA2434565A1 (en) 2002-08-08
DK1363614T3 (da) 2005-05-30
DE60203882T2 (de) 2006-02-02
ATE293966T1 (de) 2005-05-15
AR035778A1 (es) 2004-07-14
ZA200305201B (en) 2004-05-17

Similar Documents

Publication Publication Date Title
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
BR0314048B1 (pt) dispositivo vaginal para incontinÊncia urinÁria
AP2004002997A0 (en) Heterocyclic compounds for use in the treatment ofdisorders of the urinary tract.
DE60205514D1 (de) Wegwerfwindel
EE04416B1 (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
FR2838629B1 (fr) Dispositif de traitement de l'incontinence urinaire
NO20034473D0 (no) Anvendelse av selektive cox-2-inhibitorer ved behandling av urininkontinens
DK1516596T3 (da) Forbedret system til behandling af stress-urinkontinens
HUP0302430A3 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience
DE50207870D1 (de) Abschlussbandage
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
EE200300357A (et) 2-amino-1-(4-hüdroksü-3-metaansulfoonamidofenüül)-etanooli kasutamine uriinipidamatuse raviks
NO20012569D0 (no) Anvendelse av aryl-substituerte syklobutylaminer for behandling av urininkontinens
HUP0303268A3 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
EE200300379A (et) Alküülfenüüliminoimidasolidiini derivaadid uriinipidamatuse ravimiseks
EE200300177A (et) m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks
FI20011540L (fi) Miesten kertakäyttöinen virtsainkontinenssisuoja
ES1047068Y (es) Juego de cuerpos lastrados para el tratamiento de la incontinencia urinaria.
DK1330255T3 (da) Præparat af cimicifuga til behandling af inkontinens
BR8103426Y1 (pt) absorvente para incontinência urinária masculina.
SI1353660T1 (sl) Uporaba substituiranih 6-dimetilaminometil-1-fenil-cikloheksanskih spojin za terapijo urinske inkontinence
AU2002253007A1 (en) Instrumentation for the operative treatment of urinary incontinence in women
FI20002756A0 (fi) Uusi hoitomenetelmä